Joel Lewis
2023
In 2023, Joel Lewis earned a total compensation of $963.6K as Chief Executive Officer & President at Galectin Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Bonus | $289,000 |
|---|---|
| Option Awards | $55,924 |
| Salary | $573,583 |
| Other | $45,140 |
| Total | $963,647 |
Lewis received $573.6K in salary, accounting for 60% of the total pay in 2023.
Lewis also received $289K in bonus, $55.9K in option awards and $45.1K in other compensation.
Rankings
In 2023, Joel Lewis' compensation ranked 1,250th out of 2,949 executives tracked by ExecPay. In other words, Lewis earned more than 57.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,250 out of 2,949 | 58th |
Division Manufacturing | 744 out of 1,622 | 54th |
Major group Chemicals And Allied Products | 499 out of 904 | 45th |
Industry group Drugs | 487 out of 867 | 44th |
Industry Pharmaceutical Preparations | 337 out of 625 | 46th |
Source: SEC filing on December 3, 2024.
Lewis' colleagues
We found two more compensation records of executives who worked with Joel Lewis at Galectin Therapeutics in 2023.